Preliminary research show conolidine may inhibit particular ion channels, lowering neuronal excitability and restricting soreness signals. This system is particularly relevant in neuropathic suffering, where abnormal signaling will cause persistent discomfort. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to soreness notion. Computationa... https://denisy273ypg8.wikimeglio.com/user